BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zöllner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis. 2012;33:732-739. [PMID: 22287560 DOI: 10.1093/carcin/bgs020] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Abbas T, Mueller AC, Shibata E, Keaton M, Rossi M, Dutta A. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Mol Cell 2013;49:1147-58. [PMID: 23478445 DOI: 10.1016/j.molcel.2013.02.003] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
2 Liang LB, Zhu WJ, Chen XM, Luo FM. Plasma miR-30a-5p as an early novel noninvasive diagnostic and prognostic biomarker for lung cancer. Future Oncol 2019;15:3711-21. [PMID: 31664862 DOI: 10.2217/fon-2019-0393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Wang PY, Sun YX, Zhang S, Pang M, Zhang HH, Gao SY, Zhang C, Lv CJ, Xie SY. Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors. FEBS Lett. 2013;587:2675-2681. [PMID: 23850892 DOI: 10.1016/j.febslet.2013.07.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yu LN, Zhang QL, Li X, Hua X, Cui YM, Zhang NJ, Liao WT, Ding YQ. Tiam1 transgenic mice display increased tumor invasive and metastatic potential of colorectal cancer after 1,2-dimethylhydrazine treatment. PLoS One. 2013;8:e73077. [PMID: 24069171 DOI: 10.1371/journal.pone.0073077] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
5 Xiao J, Li G, Zhou J, Wang S, Liu D, Shu G, Zhou J, Ren F. MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting Defective in Cullin Neddylation 1 Domain Containing 1 (DCUN1D1). Oncol Res 2018;26:593-604. [PMID: 28470146 DOI: 10.3727/096504017X14920318811712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
6 Strubberg AM, Madison BB. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech. 2017;10:197-214. [PMID: 28250048 DOI: 10.1242/dmm.027441] [Cited by in Crossref: 57] [Cited by in F6Publishing: 63] [Article Influence: 11.4] [Reference Citation Analysis]
7 Cătană CS, Pichler M, Giannelli G, Mader RM, Berindan-Neagoe I. Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma. Oncotarget 2017;8:29519-34. [PMID: 28392501 DOI: 10.18632/oncotarget.15706] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
8 Ng YP, Chen Y, Hu Y, Ip FC, Ip NY. Olean-12-eno[2,3-c] [1,2,5]oxadiazol-28-oic acid (OEOA) induces G1 cell cycle arrest and differentiation in human leukemia cell lines. PLoS One 2013;8:e63580. [PMID: 23696836 DOI: 10.1371/journal.pone.0063580] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
9 Ress AL, Perakis S, Pichler M. microRNAs and Colorectal Cancer. Adv Exp Med Biol 2015;889:89-103. [PMID: 26658998 DOI: 10.1007/978-3-319-23730-5_6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Cheng YY, Wright CM, Kirschner MB, Williams M, Sarun KH, Sytnyk V, Leshchynska I, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, van Zandwijk N, Lin RC, Reid G. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Mol Cancer 2016;15:44. [PMID: 27245839 DOI: 10.1186/s12943-016-0529-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
11 Wei X, Wang B, Wang Q, Yang X, Yang Y, Fang Z, Yi C, Shi L, Fan X, Tao J, Guo Y, Song D. MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI. Front Pharmacol 2020;11:164. [PMID: 32194406 DOI: 10.3389/fphar.2020.00164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Dar A, Wu D, Lee N, Shibata E, Dutta A. 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. Mol Cell Biol 2014;34:4049-61. [PMID: 25154416 DOI: 10.1128/MCB.00838-14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
13 Yan J, Xu Y, Wang H, Du T, Chen H. MicroRNA-503 inhibits the proliferation and invasion of breast cancer cells via targeting insulin-like growth factor 1 receptor. Mol Med Rep 2017;16:1707-14. [PMID: 28656281 DOI: 10.3892/mmr.2017.6816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Hattori H, Janky R, Nietfeld W, Aerts S, Madan Babu M, Venkitaraman AR. p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response. Cell Cycle 2014;13:2572-86. [PMID: 25486198 DOI: 10.4161/15384101.2015.942209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
15 Masson AL, Talseth-Palmer BA, Evans TJ, Grice DM, Duesing K, Hannan GN, Scott RJ. Copy number variation in hereditary non-polyposis colorectal cancer. Genes (Basel) 2013;4:536-55. [PMID: 24705261 DOI: 10.3390/genes4040536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
16 Schetter AJ, Okayama H, Harris CC. The role of microRNAs in colorectal cancer. Cancer J. 2012;18:244-252. [PMID: 22647361 DOI: 10.1097/ppo.0b013e318258b78f] [Cited by in Crossref: 170] [Cited by in F6Publishing: 102] [Article Influence: 17.0] [Reference Citation Analysis]
17 Keshavarzi M, Sorayayi S, Jafar Rezaei M, Mohammadi M, Ghaderi A, Rostamzadeh A, Masoudifar A, Mirzaei H. MicroRNAs‐Based Imaging Techniques in Cancer Diagnosis and Therapy. J Cell Biochem 2017;118:4121-8. [DOI: 10.1002/jcb.26012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
18 Yang X, Zhong X, Tanyi JL, Shen J, Xu C, Gao P, Zheng TM, DeMichele A, Zhang L. mir-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells. Biochem Biophys Res Commun. 2013;431:617-622. [PMID: 23274497 DOI: 10.1016/j.bbrc.2012.12.083] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 6.9] [Reference Citation Analysis]
19 Tan H, Yao H, Lie Z, Chen G, Lin S, Zhang Y. MicroRNA‑30a‑5p promotes proliferation and inhibits apoptosis of human pulmonary artery endothelial cells under hypoxia by targeting YKL‑40. Mol Med Rep 2019;20:236-44. [PMID: 31115541 DOI: 10.3892/mmr.2019.10251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
20 Li M, Jin X, Guo F, Wu G, Wu L, Deng S. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma. J Cell Biochem 2019;120:15397-409. [PMID: 31037778 DOI: 10.1002/jcb.28807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Kuo WT, Su MW, Lee YL, Chen CH, Wu CW, Fang WL, Huang KH, Lin WC. Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets. J Clin Med 2015;4:1798-814. [PMID: 26389959 DOI: 10.3390/jcm4091798] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
22 Wang K, Jia Z, Zou J, Zhang A, Wang G, Hao J, Wang Y, Yang S, Pu P. Analysis of hsa-miR-30a-5p expression in human gliomas. Pathol Oncol Res 2013;19:405-11. [PMID: 23606081 DOI: 10.1007/s12253-012-9593-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
23 Ye JJ, Cao J. MicroRNAs in colorectal cancer as markers and targets: Recent advances. World J Gastroenterol 2014; 20(15): 4288-4299 [PMID: 24764666 DOI: 10.3748/wjg.v20.i15.4288] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
24 Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. J Dermatol Sci 2012;68:119-26. [PMID: 23026055 DOI: 10.1016/j.jdermsci.2012.09.004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 7.5] [Reference Citation Analysis]
25 Corton JC, Witt KL, Yauk CL. Identification of p53 Activators in a Human Microarray Compendium. Chem Res Toxicol 2019;32:1748-59. [PMID: 31397557 DOI: 10.1021/acs.chemrestox.9b00052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Xie M, Qin H, Luo Q, Huang Q, He X, Yang Z, Lan P, Lian L. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73. BMC Cancer 2017;17:305. [PMID: 28464916 DOI: 10.1186/s12885-017-3291-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
27 Kawahara K, Nagata M, Yoshida R, Hirosue A, Tanaka T, Matsuoka Y, Arita H, Nakashima H, Sakata J, Yamana K, Kawaguchi S, Gohara S, Nagao Y, Hirayama M, Takahashi N, Hirayama M, Nakayama H. miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma. Biochem Biophys Rep 2021;28:101114. [PMID: 34589618 DOI: 10.1016/j.bbrep.2021.101114] [Reference Citation Analysis]
28 Meng X, Zhong J, Zeng C, Yung KKL, Zhang X, Wu X, Qu S. MiR-30a-5p Regulates GLT-1 Function via a PKCα-Mediated Ubiquitin Degradation Pathway in a Mouse Model of Parkinson's Disease. ACS Chem Neurosci 2021;12:1578-92. [PMID: 33882234 DOI: 10.1021/acschemneuro.1c00076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Liu Y, Song Y, Ma W, Zheng W, Yin H. Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia. Leuk Res 2013;37:349-56. [PMID: 23287430 DOI: 10.1016/j.leukres.2012.12.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
30 Shen Y, Katsaros D, Loo LW, Hernandez BY, Chong C, Canuto EM, Biglia N, Lu L, Risch H, Chu WM, Yu H. Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer. Oncotarget. 2015;6:8579-8592. [PMID: 25865225 DOI: 10.18632/oncotarget.3287] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
31 Wang Y, Wang F, He J, Du J, Zhang H, Shi H, Chen Y, Wei Y, Xue W, Yan J, Feng Y, Gao Y, Li D, Han J, Zhang J. miR-30a-3p Targets MAD2L1 and Regulates Proliferation of Gastric Cancer Cells. Onco Targets Ther 2019;12:11313-24. [PMID: 31908496 DOI: 10.2147/OTT.S222854] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
32 Yuan Y, Qi G, Shen H, Guo A, Cao F, Zhu Y, Xiao C, Chang W, Zheng S. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. Int J Cancer 2019;144:1584-95. [PMID: 29987896 DOI: 10.1002/ijc.31736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ruan P, Tao Z, Tan A. Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP. Biosci Rep 2018;38:BSR20171027. [PMID: 29026005 DOI: 10.1042/BSR20171027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
34 Li L, Kang L, Zhao W, Feng Y, Liu W, Wang T, Mai H, Huang J, Chen S, Liang Y, Han J, Xu X, Ye Q. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Cancer Lett 2017;400:89-98. [PMID: 28461244 DOI: 10.1016/j.canlet.2017.04.034] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 18.2] [Reference Citation Analysis]
35 Wu X, Yu M, Zhang Z, Leng F, Ma Y, Xie N, Lu F. DDB2 regulates DNA replication through PCNA-independent degradation of CDT2. Cell Biosci 2021;11:34. [PMID: 33557942 DOI: 10.1186/s13578-021-00540-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Xiao B, Wang Y, Li W, Baker M, Guo J, Corbet K, Tsalik EL, Li QJ, Palmer SM, Woods CW, Li Z, Chao NJ, He YW. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. Blood 2013;122:3365-75. [PMID: 24041574 DOI: 10.1182/blood-2013-06-510586] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 10.4] [Reference Citation Analysis]
37 Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L, Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, Ming ZJ, Li B, Chen B, Wang JR, Liu YB, Yang JM. Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin. Biochem Pharmacol 2014;87:562-70. [PMID: 24345332 DOI: 10.1016/j.bcp.2013.12.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 6.7] [Reference Citation Analysis]
38 Zhang X, Zhang Y, Yang J, Li S, Chen J. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma. Cancer Gene Ther 2015;22:475-80. [PMID: 26384136 DOI: 10.1038/cgt.2015.44] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
39 Chen Z, Zhang J, Zhang Z, Feng Z, Wei J, Lu J, Fang Y, Liang Y, Cen J, Pan Y, Huang Y, Zhou F, Chen W, Luo J. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Cell Death Dis 2017;8:e2859. [PMID: 28569782 DOI: 10.1038/cddis.2017.252] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
40 Mao Y, Fu A, Leaderer D, Zheng T, Chen K, Zhu Y. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses. BMC Cancer 2013;13:498. [PMID: 24161199 DOI: 10.1186/1471-2407-13-498] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
41 Moreno-Mateos MA, Barragán V, Torres B, Rodríguez-Mateo C, Méndez-Vidal C, Berezikov E, Mudduluru G, Allgayer H, Pintor-Toro JA. Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance. RNA 2013;19:1711-25. [PMID: 24129493 DOI: 10.1261/rna.039461.113] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
42 Grespi F, Landré V, Molchadsky A, Di Daniele N, Marsella LT, Melino G, Rotter V. Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells. Cell Death Dis 2016;7:e2567. [PMID: 28032868 DOI: 10.1038/cddis.2016.419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
43 Yu T, Gong L, Li W, Zuo Q, Cai D, Mao H, Wang L, Lin J, Xiao B. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα. Cancer Biomark 2020;27:471-84. [PMID: 32116236 DOI: 10.3233/CBM-190314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Shirafkan N, Mansoori B, Mohammadi A, Shomali N, Ghasbi M, Baradaran B. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks. Biomedicine & Pharmacotherapy 2018;97:1319-30. [DOI: 10.1016/j.biopha.2017.11.046] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 15.8] [Reference Citation Analysis]
45 Feng K, Liu Y, Xu LJ, Zhao LF, Jia CW, Xu MY. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. Biomed Pharmacother 2018;104:686-98. [PMID: 29803929 DOI: 10.1016/j.biopha.2018.05.078] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
46 Park YR, Kim SL, Lee MR, Seo SY, Lee JH, Kim SH, Kim IH, Lee SO, Lee ST, Kim SW. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer. J Cancer Res Clin Oncol 2017;143:1915-27. [PMID: 28528497 DOI: 10.1007/s00432-017-2440-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
47 Pimm ML, Hotaling J, Henty-Ridilla JL. Profilin choreographs actin and microtubules in cells and cancer. Int Rev Cell Mol Biol 2020;355:155-204. [PMID: 32859370 DOI: 10.1016/bs.ircmb.2020.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
48 van Dam PA, Rolfo C, Ruiz R, Pauwels P, Van Berckelaer C, Trinh XB, Ferri Gandia J, Bogers JP, Van Laere S. Potential new biomarkers for squamous carcinoma of the uterine cervix. ESMO Open 2018;3:e000352. [PMID: 30018810 DOI: 10.1136/esmoopen-2018-000352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
49 Eshghifar N, Badrlou E, Pouresmaeili F. The roles of miRNAs' clinical efficiencies in the colorectal cancer pathobiology: A review article. Hum Antibodies 2020;28:273-85. [PMID: 32623393 DOI: 10.3233/HAB-200417] [Reference Citation Analysis]
50 Li Z, Chen Y, Hu S, Zhang J, Wu J, Ren W, Shao N, Ying X. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Oncotarget 2016;7:82671-85. [PMID: 27705920 DOI: 10.18632/oncotarget.12340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
51 Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Cancer. 2013;49:3924-3935. [PMID: 23968734 DOI: 10.1016/j.ejca.2013.07.149] [Cited by in Crossref: 69] [Cited by in F6Publishing: 76] [Article Influence: 7.7] [Reference Citation Analysis]
52 Darzi L, Boshtam M, Shariati L, Kouhpayeh S, Gheibi A, Mirian M, Rahimmanesh I, Khanahmad H, Tabatabaiefar MA. The silencing effect of miR-30a on ITGA4 gene expression in vitro: an approach for gene therapy. Res Pharm Sci 2017;12:456-64. [PMID: 29204174 DOI: 10.4103/1735-5362.217426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
53 Mitra S, Mukherjee N, Das S, Das P, Panda CK, Chakrabarti J. Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer. Sci Rep 2014;4:6280. [PMID: 25186767 DOI: 10.1038/srep06280] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
54 Li J, Xu X, Liu C, Xi X, Wang Y, Wu X, Li H. MiR-490-5p Restrains Progression of Gastric cancer through DTL Repression. Gastroenterol Res Pract 2021;2021:2894117. [PMID: 34594374 DOI: 10.1155/2021/2894117] [Reference Citation Analysis]
55 Bi G, Yan J, Sun S, Qu X. PRRT2 inhibits the proliferation of glioma cells by modulating unfolded protein response pathway. Biochemical and Biophysical Research Communications 2017;485:454-60. [DOI: 10.1016/j.bbrc.2017.02.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
56 Ratnadiwakara M, Mohenska M, Änkö M. Splicing factors as regulators of miRNA biogenesis – links to human disease. Seminars in Cell & Developmental Biology 2018;79:113-22. [DOI: 10.1016/j.semcdb.2017.10.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
57 Yao Y, Charlesworth J, Nair V, Watson M. MicroRNA expression profiles in avian haemopoietic cells. Front Genet 2013;4:153. [PMID: 23967013 DOI: 10.3389/fgene.2013.00153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Chen W, Gao C, Liu Y, Wen Y, Hong X, Huang Z. Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer. Front Genet 2020;11:478. [PMID: 32582275 DOI: 10.3389/fgene.2020.00478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
59 Noori J, Haghjooy Javanmard S, Sharifi M. The role of microRNA-30a and downstream snail1 on the growth and metastasis of melanoma tumor. Iran J Basic Med Sci 2019;22:534-40. [PMID: 31217934 DOI: 10.22038/IJBMS.2019.32317.7745] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
60 Zhong B, Guo S, Zhang W, Zhang C, Wang Y, Zhang C. Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN. BMC Med Genomics 2017;10:64. [PMID: 29141684 DOI: 10.1186/s12920-017-0300-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
61 Igci YZ, Ozkaya M, Korkmaz H, Bozgeyik E, Bayraktar R, Ulasli M, Erkilic S, Eraydin A, Oztuzcu S. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples. Genet Test Mol Biomarkers 2015;19:418-23. [PMID: 26047355 DOI: 10.1089/gtmb.2015.0062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
62 Shrestha S, Yang CD, Hong HC, Chou CH, Tai CS, Chiew MY, Chen WL, Weng SL, Chen CC, Chang YA, Lee ML, Huang WY, Hsu SD, Chen YC, Huang HD. Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A. Int J Mol Sci 2017;19:E87. [PMID: 29283424 DOI: 10.3390/ijms19010087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
63 Ye L, Jiang T, Shao H, Zhong L, Wang Z, Liu Y, Tang H, Qin B, Zhang X, Fan J. miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2. Mol Ther Nucleic Acids. 2017;7:453-464. [PMID: 28624221 DOI: 10.1016/j.omtn.2017.05.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
64 Baraniskin A, Chomiak M, Ahle G, Gress T, Buchholz M, Turewicz M, Eisenacher M, Margold M, Schlegel U, Schmiegel W, Hahn S, Schroers R. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS. J Neurooncol 2018;137:463-8. [PMID: 29327175 DOI: 10.1007/s11060-018-2749-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
65 Jiang L, Zang D, Yi S, Li X, Yang C, Dong X, Zhao C, Lan X, Chen X, Liu S, Liu N, Huang H, Shi X, Wang X, Liu J. A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment. Sci Rep 2016;6:21565. [PMID: 26898246 DOI: 10.1038/srep21565] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
66 Liao WT, Ye YP, Zhang NJ, Li TT, Wang SY, Cui YM, Qi L, Wu P, Jiao HL, Xie YJ, Zhang C, Wang JX, Ding YQ. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J Pathol 2014;232:415-27. [PMID: 24293274 DOI: 10.1002/path.4309] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 12.4] [Reference Citation Analysis]
67 Yang XJ, Si RH, Liang YH, Ma BQ, Jiang ZB, Wang B, Gao P. Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway. World J Gastroenterol 2016; 22(15): 3978-3991 [PMID: 27099441 DOI: 10.3748/wjg.v22.i15.3978] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
68 Noori J, Sharifi M, Haghjooy Javanmard S. miR-30a Inhibits Melanoma Tumor Metastasis by Targeting the E-cadherin and Zinc Finger E-box Binding Homeobox 2. Adv Biomed Res 2018;7:143. [PMID: 30596053 DOI: 10.4103/abr.abr_146_18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
69 Zhang S, Liu Q, Zhang Q, Liu L. MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1. Oncol Lett 2017;14:5018-26. [PMID: 29085515 DOI: 10.3892/ol.2017.6745] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
70 Cho WC. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin Ther Targets. 2012;16:747-759. [PMID: 22690697 DOI: 10.1517/14728222.2012.696102] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
71 Chung YH, Li SC, Kao YH, Luo HL, Cheng YT, Lin PR, Tai MH, Chiang PH. MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells. Int J Mol Sci 2017;18:E1826. [PMID: 28829370 DOI: 10.3390/ijms18081826] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
72 Ren J, Zhou Q, Li H, Li J, Pang L, Su L, Gu Q, Zhu Z, Liu B. Characterization of exosomal RNAs derived from human gastric cancer cells by deep sequencing. Tumour Biol 2017;39:1010428317695012. [PMID: 28381156 DOI: 10.1177/1010428317695012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
73 Guo L, Luo C, Fan J, Hou Z, Ji X, Chen F, Zhu B, Ni C. Serum miRNA profiling identifies miR-150/30a as potential biomarker for workers with damaged nerve fibers from carbon disulfide. Ind Health 2015;53:38-47. [PMID: 25224332 DOI: 10.2486/indhealth.2014-0120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Ding X, Duan H, Luo H. Identification of Core Gene Expression Signature and Key Pathways in Colorectal Cancer. Front Genet 2020;11:45. [PMID: 32153633 DOI: 10.3389/fgene.2020.00045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
75 Cai X, Lin L, Zhang Q, Wu W, Su A. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer. J Int Med Res 2020;48:300060520929167. [PMID: 32527185 DOI: 10.1177/0300060520929167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
76 Soriano A, Jubierre L, Almazán-Moga A, Molist C, Roma J, de Toledo JS, Gallego S, Segura MF. microRNAs as pharmacological targets in cancer. Pharmacol Res 2013;75:3-14. [PMID: 23537752 DOI: 10.1016/j.phrs.2013.03.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
77 Luo M, Hao L, Hu F, Dong Y, Gou L, Zhang W, Wang X, Zhao Y, Jia M, Hu S, Zhang X. MicroRNA profiles and potential regulatory pattern during the early stage of spermatogenesis in mice. Sci China Life Sci 2015;58:442-50. [DOI: 10.1007/s11427-014-4737-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
78 Sun Y, Yang B, Lin M, Yu H, Chen H, Zhang Z. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.Cancer Biomark. 2019;24:299-305. [PMID: 30829615 DOI: 10.3233/CBM-182129] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
79 Schetter AJ, Okayama H, Harris CC. The role of microRNAs in colorectal cancer. Cancer J. 2012;18:244-252. [PMID: 22647361 DOI: 10.1097/PPO.0b013e318258b78] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Gutiérrez ML, Corchete L, Teodosio C, Sarasquete ME, del Mar Abad M, Iglesias M, Esteban C, Sayagues JM, Orfao A, Muñoz-Bellvis L. Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas. Oncotarget 2015;6:19070-86. [PMID: 26053098 DOI: 10.18632/oncotarget.4233] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
81 Yuan Y, Zheng S, Li Q, Xiang X, Gao T, Ran P, Sun L, Huang Q, Xie F, Du J, Xiao C. Overexpression of miR-30a in lung adenocarcinoma A549 cell line inhibits migration and invasion via targeting EYA2. Acta Biochim Biophys Sin (Shanghai) 2016;48:220-8. [PMID: 26837415 DOI: 10.1093/abbs/gmv139] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
82 Jiang LH, Zhang HD, Tang JH. MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer. J Oncol 2018;2018:5167829. [PMID: 30158978 DOI: 10.1155/2018/5167829] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
83 Liu R, Zhang Y, Sun P, Wang C. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP. Open Biol 2020;10:190173. [PMID: 32343928 DOI: 10.1098/rsob.190173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
84 Guo Y, Sun W, Gong T, Chai Y, Wang J, Hui B, Li Y, Song L, Gao Y. miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM. Oncol Rep 2017;37:1980-8. [PMID: 28259977 DOI: 10.3892/or.2017.5448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
85 Nassa G, Tarallo R, Giurato G, De Filippo MR, Ravo M, Rizzo F, Stellato C, Ambrosino C, Baumann M, Lietzèn N, Nyman TA, Weisz A. Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs. Mol Cell Proteomics 2014;13:1076-90. [PMID: 24525454 DOI: 10.1074/mcp.M113.030403] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
86 Skaar JR, Pagan JK, Pagano M. SCF ubiquitin ligase-targeted therapies. Nat Rev Drug Discov 2014;13:889-903. [PMID: 25394868 DOI: 10.1038/nrd4432] [Cited by in Crossref: 194] [Cited by in F6Publishing: 186] [Article Influence: 24.3] [Reference Citation Analysis]
87 Chen N, Chon HS, Xiong Y, Marchion DC, Judson PL, Hakam A, Gonzalez-Bosquet J, Permuth-Wey J, Wenham RM, Apte SM, Cheng JQ, Sellers TA, Lancaster JM. Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel. Oncol Rep 2014;31:376-83. [PMID: 24220856 DOI: 10.3892/or.2013.2847] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
88 Stevens A, Meyer S, Hanson D, Clayton P, Donn RP. Network analysis identifies protein clusters of functional importance in juvenile idiopathic arthritis. Arthritis Res Ther 2014;16:R109. [PMID: 24886659 DOI: 10.1186/ar4559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
89 Fu X, Zhang W, Su Y, Lu L, Wang D, Wang H. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer. Prostate 2016;76:543-51. [PMID: 26771762 DOI: 10.1002/pros.23143] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
90 Amirkhah R, Schmitz U, Linnebacher M, Wolkenhauer O, Farazmand A. MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression. Genes Chromosomes Cancer. 2015;54:129-141. [PMID: 25620079 DOI: 10.1002/gcc.22231] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
91 Kumar S, Gupta P, Khanal S, Shahi A, Kumar P, Sarin SK, Venugopal SK. Overexpression of microRNA-30a inhibits hepatitis B virus X protein-induced autophagosome formation in hepatic cells. FEBS J 2015;282:1152-63. [DOI: 10.1111/febs.13209] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
92 Du B, Dai XM, Li S, Qi GL, Cao GX, Zhong Y, Yin PD, Yang XS. MiR-30c regulates cisplatin-induced apoptosis of renal tubular epithelial cells by targeting Bnip3L and Hspa5. Cell Death Dis 2017;8:e2987. [PMID: 28796263 DOI: 10.1038/cddis.2017.377] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
93 Schubert SA, Ruano D, Elsayed FA, Boot A, Crobach S, Sarasqueta AF, Wolffenbuttel B, van der Klauw MM, Oosting J, Tops CM, van Eijk R, Vasen HF, Vossen RH, Nielsen M, Castellví-Bel S, Ruiz-Ponte C, Tomlinson I, Dunlop MG, Vodicka P, Wijnen JT, Hes FJ, Morreau H, de Miranda NF, Sijmons RH, van Wezel T. Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia. Br J Cancer 2017;117:1215-23. [PMID: 28742792 DOI: 10.1038/bjc.2017.240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
94 Olivero M, Dettori D, Arena S, Zecchin D, Lantelme E, Di Renzo MF. The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase. Oncotarget 2014;5:5992-6002. [PMID: 25115388 DOI: 10.18632/oncotarget.2042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
95 Liu H, Zhang Z, Wu N, Guo H, Zhang H, Fan D, Nie Y, Liu Y. Integrative Analysis of Dysregulated lncRNA-Associated ceRNA Network Reveals Functional lncRNAs in Gastric Cancer. Genes (Basel) 2018;9:E303. [PMID: 29912172 DOI: 10.3390/genes9060303] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
96 Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv G, Zou Z, Jiang XC, Zou C, Liu W, Luo J, Zhao Z, Muhammad S, Wang G, Chen YG, Wang X. Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol Cell Biol 2015;35:988-1000. [PMID: 25582198 DOI: 10.1128/MCB.01242-14] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
97 Abbas T, Keaton M, Dutta A. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2. Cell Cycle 2013;12:2175-82. [PMID: 23892434 DOI: 10.4161/cc.25314] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
98 Jiang L, Liu Y, Ma C, Li B. MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9. Oncol Lett 2018;16:3038-44. [PMID: 30127894 DOI: 10.3892/ol.2018.8999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
99 Jin H, Shi X, Zhao Y, Peng M, Kong Y, Qin D, Lv X. MicroRNA-30a Mediates Cell Migration and Invasion by Targeting Metadherin in Colorectal Cancer. Technol Cancer Res Treat 2018;17:1533033818758108. [PMID: 29478367 DOI: 10.1177/1533033818758108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
100 Wu L, Yang K, Gui Y, Wang X. Nicotine-upregulated miR-30a arrests cell cycle in G1 phase by directly targeting CCNE2 in human periodontal ligament cells. Biochem Cell Biol 2020;98:354-61. [PMID: 31689122 DOI: 10.1139/bcb-2019-0156] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
101 Wu Y, Zhang J, Hou S, Cheng Z, Yuan M. Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB. Biotechnol Lett 2017;39:1827-34. [DOI: 10.1007/s10529-017-2428-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
102 Zhou L, Jia S, Ding G, Zhang M, Yu W, Wu Z, Cao L. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma. J Cancer 2019;10:5031-40. [PMID: 31602254 DOI: 10.7150/jca.31191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
103 Mika T, Ladigan-Badura S, Maghnouj A, Mustafa B, Klein-Scory S, Baraniskin A, Döhring S, Fuchs I, Ehl S, Hahn SA, Schroers R. Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy. Front Oncol 2020;10:568056. [PMID: 33363008 DOI: 10.3389/fonc.2020.568056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Zhang F, Qiao S. Research Progress on the Relationship Between Inflammation and Colorectal Cancer. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12517] [Reference Citation Analysis]
105 Jia Z, Wang K, Wang G, Zhang A, Pu P. MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7. PLoS One 2013;8:e55008. [PMID: 23383034 DOI: 10.1371/journal.pone.0055008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
106 Cha HJ, Kim OY, Lee GT, Lee KS, Lee JH, Park IC, Lee SJ, Kim YR, Ahn KJ, An IS, An S, Bae S. Identification of ultraviolet B radiation‑induced microRNAs in normal human dermal papilla cells. Mol Med Rep 2014;10:1663-70. [PMID: 25069581 DOI: 10.3892/mmr.2014.2418] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
107 Zöllner H, Hahn SA, Maghnouj A. Lentiviral overexpression of miRNAs. Methods Mol Biol 2014;1095:177-90. [PMID: 24166313 DOI: 10.1007/978-1-62703-703-7_15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
108 Liu Y, Zhou Y, Gong X, Zhang C. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor. Exp Ther Med 2017;14:173-80. [PMID: 28672911 DOI: 10.3892/etm.2017.4477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
109 Shen Y, Tong M, Liang Q, Guo Y, Sun HQ, Zheng W, Ao L, Guo Z, She F. Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells. Pharmacogenomics J 2018;18:23-8. [PMID: 28045128 DOI: 10.1038/tpj.2016.91] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
110 Newie I, Søkilde R, Persson H, Grabau D, Rego N, Kvist A, von Stedingk K, Axelson H, Borg Å, Vallon-Christersson J, Rovira C. The HER2-encoded miR-4728-3p regulates ESR1 through a non-canonical internal seed interaction. PLoS One 2014;9:e97200. [PMID: 24828673 DOI: 10.1371/journal.pone.0097200] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
111 Xuan Y, Yang H, Zhao L, Lau WB, Lau B, Ren N, Hu Y, Yi T, Zhao X, Zhou S. MicroRNAs in colorectal cancer: Small molecules with big functions. Cancer Lett. 2014; Dec 15. [Epub ahead of print]. [PMID: 25524553 DOI: 10.1016/j.canlet.2014.11.051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
112 Lei SL, Zhao H, Yao HL, Chen Y, Lei ZD, Liu KJ, Yang Q. Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol Lett 2014;8:1768-74. [PMID: 25202407 DOI: 10.3892/ol.2014.2328] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
113 Jiang S, Miao D, Wang M, Lv J, Wang Y, Tong J. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. J Cell Mol Med 2019;23:630-40. [PMID: 30338942 DOI: 10.1111/jcmm.13968] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
114 Orosz E, Kiss I, Gyöngyi Z, Varjas T. Expression of Circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: Comparison of Colonic and Rectal Cancer. In Vivo 2018;32:1333-7. [PMID: 30348685 DOI: 10.21873/invivo.11383] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
115 Bai WL, Dang YL, Yin RH, Jiang WQ, Wang ZY, Zhu YB, Wang SQ, Zhao YY, Deng L, Luo GB, Yang SH. Differential Expression of microRNAs and their Regulatory Networks in Skin Tissue of Liaoning Cashmere Goat during Hair Follicle Cycles. Anim Biotechnol 2016;27:104-12. [PMID: 26913551 DOI: 10.1080/10495398.2015.1105240] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
116 Zhang H, Zou J, Yin Y, Zhang B, Hu Y, Wang J, Mu H. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma. PeerJ 2019;7:e8096. [PMID: 31788359 DOI: 10.7717/peerj.8096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]